Abraham Ceesay

CIK 1722140 · Chief Executive Officer · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$22.90M

Companies

6

Total Filings

23

Lifetime Open-Market Net

-$6.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRL Director 2,384 $187.51 $447.0K $0 2 2026-05-11
RAPP Chief Executive Officer 579,257 $38.40 $22.24M -$3.50M 9 2026-02-19
PCRX Director 9,039 $22.99 $207.8K -$64.0K 4 2025-09-08
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted President 19,210 $44.96 $863.7K -$3.26M 6 2023-02-08
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted President $18.07 $0 1 2021-06-03
scPharmaceuticals Inc. (SCPH) Delisted Chief Operating Officer $5.67 $0 1 2018-01-19

Recent Filings · Page 3 of 3

23 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-02-11 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Grant (A) $0 EDGAR
2021-06-03 Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted Grant (A) $0 EDGAR
2018-01-19 scPharmaceuticals Inc. (SCPH) Delisted Grant (A) $0 EDGAR
Showing 2123 of 23
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.